World Health Organization (WHO)’s Science in 5 | Ep.110 Dive into the crucial topic of substandard medical products and falsified treatments. Learn how WHO safeguards your health. Pernette Bourdillon Esteve breaks it down in this eye-opening episode!
The following message is courtesy of Dr Raffaella Ravinetto, Public Health Department, Institute of Tropical Medicine Antwerp, Belgium. Ref. Cavany S, Nanyonga S, Hauk C, Lim C, Tarning J, Sartorius B, Dolecek C, Caillet C, Newton PN, Cooper BS. The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance. Nat ...
Join the 5th International PPRI Conference in Vienna on April 25-26, 2024! Engage with top-tier academics, policymakers, and stakeholders to explore innovative pharmaceutical policies for affordable access to medicines. Submit abstracts by January 15, 2024, for a chance to present in dedicated sessions. Details at https://ppri.goeg.at/ppriconference2024. Don’t miss the chance to shape future policies!
To our incredible Quamed community: as we embrace the magic of Christmas, we’re taking some time off to cherish moments with loved ones. Our offices will be closed from December 22nd, and we’ll return on January 2nd, rejuvenated and eager to continue our journey with you. Thank you for being with us! May your holidays ...
QUAMED is proud to announce that we have issued the first 2 QCP certificates. Our Independent Decision Committee (IDC) has issued a QCP GSDP certificate to BaDM, a pharmaceutical distributor based in Ukraine. The IDC has also issued a QCP MQAS certificate to Imres, an international pharmaceutical distributor based in the Netherlands. The certificate register ...
QUAMED is happy to announce that its board of directors has accepted the Medical Export Group membership applications (in the Netherlands) and CHMP (in Kenya) as adherent members of our association. The board has also accepted the application of Mr. George Mugi as an associative member. We have been working and communicating with all three ...
The recent Bloomberg post by Kendall Taggart and Priyanka Pulla highlights the tragic consequences of compromised drug manufacturing, specifically focusing on an Indian pharmaceutical supplier, Naprod Life Sciences. The narrative revolves around an investigative report shedding light on the distressing aftermath of contaminated medications distributed by Naprod. In Colombia, four children lost their lives, and over a hundred ...
Medical Product Alert N°8/2023 Substandard (contaminated) syrup and suspension medicines have been identified in multiple WHO regions, including the Americas, Eastern Mediterranean, Southeast Asia, and the Western Pacific. Five products from PHARMIX LABORATORIES (PVT.) LTD, including ALERGO Syrup and ULCOFIN Suspension, have been found with dangerous levels of ethylene glycol, posing severe health risks like ...
The E-Drug Community is thrilled to reintroduce E-Drug as E-Drug Plus, aiming to offer the same engagement opportunities as before! By registering at https://talk.edrugplus.org/login and resetting your password using your previous email, you’ll regain access to the familiar email digests and enjoy interactive features on the new platform. Dive back into the community and stay informed! ...
This week, we had the privilege to participate in the 2023 Joint UNICEF, UNFPA and WHO meeting with manufacturers and suppliers in Copenhagen. It was an opportunity to learn from colleagues about the latest developments around the UN organisations’ approach to pharmaceutical quality assurance and procurement. The session on Regulatory Updates was especially interesting. It ...
Would you like more information about audits or get a quote? Do not hesitate to contact us via the contact form.
En poursuivant votre visite sur ce site, vous acceptez l'utilisation de cookies En savoir plus
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.